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Human natural killer (NK) cells and their antileukemic
potential have been of rising interest over the last years.
However, it is controversially discussed how NK cells can
be best exploited for anti-leukemic therapy in the clinic.
Accordingly, we performed a first detailed analysis of the
NK cell repertoire specific for childhood ALL in order to
investigate the participation of NK cell subsets in the kill-
ing of pediatric leukemic blasts. PBMCs from 4 healthy
volunteer samples were incubated with ALL blasts of two
pediatric patients. We observed a variable frequency of
NK cells (0.5%-15.6%) that showed degranulation of
CD107 in the presence of ALL blasts and this frequency
was strongly dependent on the donor. In a next step NK
cells were characterized by means of KIR2DL1, KIR2DL3
and NKG2A by 6-color flow cytometry. Analysis of
CD107 mobilization revealed that especially single-KIR+
NK cells showed the highest killing ability: in single-
KIR2DL1+ NK cells the frequency of CD107+ cells was
7.6% and in single-KIR2DL3+ cells 6.7%. In contrast, NK
cells not expressing any of these three receptors had a
reduced anti-leukemic activity, which is compatible with
previous studies showing that KIR-NKG2A- NK cells are
hyporesponsive. In general, KIR+NKG2A- NK cells
appeared to have the highest frequency of anti-leukemic
NK cells in our experiments, whereas KIR-NKG2A-
consistently showed the lowest reactivity. In summary, our
results showed that participation of NK cell subsets in
ALL killing is dependent on respective expression levels
and expression clusters of KIR and other receptors. Single
KIR+ NK cell subsets appeared to be most effective against
childhood ALL blasts. With further advancements in isola-
tion and expansion techniques, development of novel
characterized ALL-specific NK cells appears feasible for
future donor-derived NK cell transfer as supportive
treatment in childhood ALL.
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